166 related articles for article (PubMed ID: 7394328)
1. Diester metabolites of the flame retardant chemicals, tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl) phosphate in the rat: identification and quantification.
Lynn RK; Wong K; Dickinson RG; Gerber N; Kennish JM
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):351-60. PubMed ID: 7394328
[No Abstract] [Full Text] [Related]
2. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat.
Lynn RK; Wong K; Garvie-Gould C; Kennish JM
Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442
[TBL] [Abstract][Full Text] [Related]
3. Irreversible macromolecular binding of the flame retardant tris-(2, 3-dibromopropyl)phosphate in vitro and in vivo.
Dybing E; Söderlund EJ; Nelson SD
Dev Toxicol Environ Sci; 1980; 8():265-8. PubMed ID: 7308025
[No Abstract] [Full Text] [Related]
4. Tris(2,3-dibromopropyl) phosphate.
IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():575-88. PubMed ID: 397179
[No Abstract] [Full Text] [Related]
5. A comparison of the genotoxic properties of tris(2,3-dibromopropyl)phosphate and tris(1,3-dichloro-2-propyl)phosphate in a battery of short-term bioassays.
Brusick D; Matheson D; Jagannath DR; Goode S; Lebowitz H; Reed M; Roy G; Benson S
J Environ Pathol Toxicol; 1979 Dec; 3(1-2):207-26. PubMed ID: 121137
[No Abstract] [Full Text] [Related]
6. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
Gold MD; Blum A; Ames BN
Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of toxic and neoplastic renal lesions induced by the flame retardant tris (2,3-dibromopropyl)phosphate in F344 rats, and development of colonic adenomas after prolonged oral administration.
Reznik G; Reznik-Schüller HM; Rice JM; Hague BF
Lab Invest; 1981 Jan; 44(1):74-83. PubMed ID: 7453132
[TBL] [Abstract][Full Text] [Related]
8. The metabolism and disposition of tris(1,3-dichloro-2-propyl) phosphate (Fyrol FR-2) in the rat.
Nomeir AA; Kato S; Matthews HB
Toxicol Appl Pharmacol; 1981 Mar; 57(3):401-13. PubMed ID: 7222047
[No Abstract] [Full Text] [Related]
9. Thermal oxidative degradation studies of phosphate esters.
Paciorek KJ; Kratzer RH; Kaufman J; Nakahara JH; Christos T; Hartstein AM
Am Ind Hyg Assoc J; 1978 Aug; 39(8):633. PubMed ID: 696625
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
Lynn RK; Garvie-Gould C; Wong K; Kennish JM
Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
[No Abstract] [Full Text] [Related]
11. Quantification of two urinary metabolites of organophosphorus flame retardants by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Schindler BK; Förster K; Angerer J
Anal Bioanal Chem; 2009 Oct; 395(4):1167-71. PubMed ID: 19763550
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of tris(2-chloroethyl) phosphate in rats and mice.
Burka LT; Sanders JM; Herr DW; Matthews HB
Drug Metab Dispos; 1991; 19(2):443-7. PubMed ID: 1676651
[TBL] [Abstract][Full Text] [Related]
13. Determination of human urinary organophosphate flame retardant metabolites by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Schindler BK; Förster K; Angerer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):375-81. PubMed ID: 19121980
[TBL] [Abstract][Full Text] [Related]
14. First insights in the metabolism of phosphate flame retardants and plasticizers using human liver fractions.
Van den Eede N; Maho W; Erratico C; Neels H; Covaci A
Toxicol Lett; 2013 Oct; 223(1):9-15. PubMed ID: 23994729
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of Tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue.
Salamone MF; Katz M
J Natl Cancer Inst; 1981 Apr; 66(4):691-5. PubMed ID: 6939915
[TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. I. Covalent binding and reactive metabolite formation in vitro.
Pearson PG; Omichinski JG; McClanahan RH; Søderlund EJ; Dybing E; Nelson SD
Toxicol Appl Pharmacol; 1993 Feb; 118(2):186-95. PubMed ID: 8441997
[TBL] [Abstract][Full Text] [Related]
17. [The structures of two chemicals sometimes misunderstood as tris-(2,3-dibromopropyl)phosphate in the official analytical method].
Nakamura A; Kojima S; Kaniwa M
Eisei Shikenjo Hokoku; 1986; (104):109-13. PubMed ID: 3567421
[No Abstract] [Full Text] [Related]
18. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. II. Covalent binding, reactive metabolite formation, and differential metabolite-specific DNA damage in vivo.
Pearson PG; Omichinski JG; Holme JA; McClanahan RH; Brunborg G; Søderlund EJ; Dybing E; Nelson SD
Toxicol Appl Pharmacol; 1993 Feb; 118(2):196-204. PubMed ID: 8441998
[TBL] [Abstract][Full Text] [Related]
19. Seasonal fluctuations of organophosphate concentrations in precipitation and storm water runoff.
Regnery J; Püttmann W
Chemosphere; 2010 Feb; 78(8):958-64. PubMed ID: 20074776
[TBL] [Abstract][Full Text] [Related]
20. In vivo binding of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(1,3-dichloro-2-propyl) phosphate to macromolecules of mouse liver, kidney and muscle.
Morales NM; Matthews HB
Bull Environ Contam Toxicol; 1980 Jul; 25(1):34-8. PubMed ID: 6161654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
